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TRlCHIURA I FECTIO I
DURBAN, SOUTH AFRICA
T F H G Jackson, S R Epstein, E Gouws, R F Cheetham
Objective. To compare the efficacy of mebendazole 500 mg
and aIbendazole 400 mg single-close treatments of Trichuris
trichiura infection in children in the Durban area of KwaZulu-
atal, South Africa.
Design. A single-blind randomised trial in children with a
documented moderate infection of T. mchiura. Ova were
counted in stool specimens before and 10 days after
treatment by the formal-ether concentration method.
Setting. Two shelters for abandoned and orphaned children
in Durban.
Participants. inety-six children aged between 2 and 12
years.
Outcome measures. The number of children who showed
reduced T. trichiura ova counts after the treatments, and
reductions in ova counts, both expressed as percentages.
Statistical analysis using the Wilcoxon 2-sample test and the
chi-square test.
Results. Eighty-two children completed the trial; 42 received
mebendazole and 40 albendazole. Of the mebendazole group
85% showed a reduction in T. trichiura ova count, compared
with 75% of children who received albendazole.
Mebendazole treatment was associated with a median
percentage reduction in ova count of 72.2%, which
significantly exceeded the 44.1% reduction after albendazole
(P = 0.024).
Conclusian. The mebendazole 500 mg single-close therapy
was more efficacious than the albendazole 400 mg single-
dose therapy in treating T. trichiura infection in these
children.
S Afr Med J1998; 88: 880-883.
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Trichuriasis is an extensive worldwide health problem with
estimates indicating that some 500 million people are infected
with Trichuris,' Although found in all communities, parasitic
diseases tend to be associated with poverty, and one estimate
of the prevalence of T. trichiuYa infections in school-going
children in a peri-urban area of KwaZulu- latal is 47%-'
Intestinal parasitic infections impact on morbidity widely.
Trichuriasis has been associated with protein energy
malnutrition,' which in turn has behavioural and cognitive
effects. In a Jamaican study by Simeon et ai' it was shown that
T. trichiura infection combined with poor nutritional status had
an adverse effect on school performance. Trichuriasis has also
possibly been linked with poor attention in school-going
children.' T. trichillYa infection is one of the most difficult
parasitic infections to treat effectively. For example, Hall and
aharS found that although albendazole initially appeared to
inhibit ova production, it was later resumed. Results of other
investigations also support the fact that trichuriasis is more
difficult to treat than other parasitic infections such as
ascariasis and hookworm.·.7
Mebendazole and albendazole are both benzimidazole
carbamate drugs. Mebendazole has a broad spectrum of
anthelmintic activity, including trichuriasis, hookworm,
ascariasis, enterobiasis, strongyloidiasis and tapeworm. The
drug is not absorbed from the host's intestine to any significant
degree and appears to work by irreversibly blocking glucose
uptake in the parasite, leading to depletion of the parasite
glycogen, decreased formation of adenosine triphosphate and
cell death.· Albendazole has a similar spectrum of activity to
mebendazole, but its mode of action differs in that it is
absorbed from the host's intestine.·
Mebendazole has been available as a multiple daily dose
formulation on the South African market for many years. The
advent of the single-dose regimen for mebendazole and the
availability of albendazole for human treatment prompted the
decision to conduct this comparative trial in South Africa.
METHODS
Subjects and stool specimens
One hundred and seventy-five children between the ages of
2 and 12 years (mean 8 years) were screened for this study.
The children lived in one of two shelters for abandoned and
orphaned children in the Durban area of KwaZulu- atal,
South Africa. Initial screening was performed to determine
which children were infected with T. trichillYa. Stool specimens
were collected in 30 ml plastic screw-cap stool jars and
preserved in 10% formal-saline. Formed stool specimens were
covered with preservative; in the case of a semi-formed stool
an equal volume of 10% formal-saline was added to the jar.
One-gram samples were then processed in duplicate by means
of the formal-ether concentration method. Total egg counts
were performed on the concentrate using a compound
microscope, and dilute Lugol's iodine was used as a stain. The
counts were expressed as eggs per gram of stool. Ninety-six
children with a moderate infection (5 - 70 ova per cover slip on
low power) were selected for the trial.
TreatInent and follo-w-up
These children then received either a single 500 mg dose of
mebendazole (Vermox; Janssen-Cilag) or a single 400 mg dose
of albendazole (Zental; SmithKline Beecham). The drugs were
packaged identically and administered under the supervision
of a clinician in a single-blind manner according to a
randomisation schedule prepared by the Janssen Research
Foundation, Belgium. The staff supervising the children were
asked to note any adverse experiences reported by them,
particularly during the 24-hour period following drug
administration.Ten days after treatment stool collections were
repeated and 1 g duplicate samples of each specimen were
processed for quantitative T. trichiura ova counts, as above.
Statistics
In order to show a 25% difference in parasite reduction
between the two treatment groups, with 80% power and
significance at the 5% level, 80 children were required to
complete the study. The distribution of the ova counts, as well
as the percentage reduction in ova counts, deviated
significantly from normality and so the results were
summarised in terms of medians and interquartile ranges. The
significance of the difference between groups was assessed
using the Wilcoxon 2-sample test. The chi-square test was used
to compare the groups with respect to the percentage of
children showing a reduction in ova burden.
Ethical approval
This study was approved by the Postgraduate (Ethics)




One hundred and fifty-three (88%) of the 175 children screened
were positive for T. trichiura infection; only 9 children were free
of parasites. Eleven other parasite species were identified, with
Giardia dllodenalis (63% of children), Entamo~ba coli (31%) and
Ascaris and Entamoeba histolytica/dispar (both 17%) being the
next most common parasites identified. Most (71%) of the
faecal samples were formed, 24% were semi-formed, and the
remaining 5% were fluid. Of the 96 children who had an
appropriate level of T. trichiura infection and who entered the
trial, 14 either were unable to provide a post-treatment stool
specimen or were lost to follow-up. Eighty-two children were
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Table I. Pre- and post-treatment ova counts (eggs per gram of
stool)
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produce a statistically significant reduced ova count of 0% in
T. trichillTa-infected individuals.
Good efficacy in treating T. tricllillTa infection was reported
by Abadib when he treated subjects from Unjung Pandang,
Indonesia, with a single 500 mg dose of mebendazole. He
reported a cure rate of 78% and an ova reduction rate of 93%.
A study conducted previously in South Africa with the
mebendazole 500 mg single-dose regimen showed a 100% cure
rate for trichuriasis in a small number of children with low ova
counts1 '
The effects and implications of untreated parasitic infections
in children, such as trichuriasis, are wider than may initially be
apparent. Three studies among Kenyan schoolchildren have
shown improved growth, appetite and spontaneous physical
activity after treatment of their mixed parasitic infections,
which included T. trichillra. Il- 15 An important finding among
Jamaican schoolchildren was that the children most likely to
benefit from treatment were those with poor nutritional status
and heavy T trichiuTa infections.'· Both in South Africa and
elsewhere it has been shown that treatment of parasitic
infections can have a positive effect on children's cognitive
processes."· Simeon et aU showed particular benefit in children
who were undernourished.
Owing to the wide implications of parasitic disease, the
control or elimination of gastro-intestinal infections such as
trichuriasis is of paramount importance in the upliftrnent of
socially and economically disadvantaged communities. In view
of the type of communities where T trichillTa is most prevalent,
the treatment of this parasitic infection must take into account
not only efficacy of the medication but also its availability and
cost. Both at the time of undertaking this research and when
reporting these results mebendazole 500 mg was available
without a doctor's prescription, making it simpler to
administer and more accessible, while albendazole 400 mg was
available only on prescription in South Africa. The price of the
two products was comparable. Our results showed both drugs
to be safe; however, mebendazole was shown to have superior
efficacy in treating T. trichillTa infections in this group of
children.
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zimande from the Othandweni Home in Lamontville, Durban,
and Mrs N Malahleha, Mr P Ndlovu and Mr S Ngcobo from the
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The randomisation schedule achieved comparable baseline
counts for each treatment, and these are summarised together
with percentage reductions in counts in Table 1. Frequency of
ova count reduction was 36/42 ( 6%) after treatment with
mebendazole and 30/40 (75%) after albendazole (P = 0.054).
The percentage reduction after mebendazole (72%) was
significantly greater (P =0.024) than after albendazole (44%).
mebendazole and 40 albendazole. TO adverse events were
reported in either group.
The results presented here indicating different efficacies
between mebendazole and albendazole in treating
T trichillra infection are reflected elsewhere in the literature."JO
In a comparative trial using the same dose regimens as this
study, Albonico et a]9 showed mebendazole to be significantly
superior to albendazole for both cure rate (P < 0.01) and
percentage ova reduction (P < 0.001) in children infected with
T. trichillra in Zanzibar. In a comparative study using 400 mg of
either mebendazole or albendazole, Bartoloni et al.' showed
mebendazole to have a higher cure rate than albendazole
(60% v. 33%), while albendazole was reported to have a higher
ova reduction rate than mebendazole (45.7% v. 15%). However,
only 25 children with T. trichillra infection participated in the
study, which may have contributed to the inconsistent results.
In a study using higher doses of both mebendazole and
albendazole (600 mg and 1 g, respectively), Holzer and Frey"
reported that both drugs had enhanced cure rates in T. trichillra
infection. Albendazole cured 90% of subjects and mebendazole
93°/0 •
Several authors have studied either mebendazole or
albendazole in an open fashion in the treatment of trichuriasis.
Ramalingam et alIi treated patients with 400 mg, 600 mg Ol" 800
mg albendazole a a single dose. The ova reduction rates on
day 21 were 39°'0, 85°0 and 73°/0 , respectively, and the cure rate
varied between 20°0 and 61°0, again with the best result in the
600 mg group. In comparison to these results, Hall and Nahar'
reported that single doses of 600 mg or 00 mg albendazole
were ineffecti\Oe and that -lOO mg for 5 days was required to
1mB
, ORIGINAL ARTICLES
2. Kvalsvig ID, Cooppan RM, Connolly KJ. The effects of parasite infections on cognitive
processes in children. Ann Trop Med Parasitol1991; 85: 551·568.
3. Stevenson lS. Impact of Helminth Infections on Human Nutrition. London: TayIar &
Francis, 1987.
4. Simeon DT, Grantham-McGreggor SM, Wong MS. Trichuris trichiura infection and
cognition in children: results of a randomized clinical trial. Parasitology 1995; 110: -l57-
.64.
5. Hall A, Nahar Q. Albendazole and infections with Ascaris lumbncoides and Trichuris
triclliuTI1 in children in Banglade::;h. Trans R 50c Trop Med Hyg 199.+; 88: 110-112.
6. Abadi K. Single dose mebendazole therapy for soil-transmitted nematodes. Am / Trop
Med Hyg 1985; 34, 129·133.
7. Bartoloni A, Guglielmetti P, Canedni G, et al. Comparati\·e efficacy of a single -400 mg
dose of albendazole or mebendazole in the treatment of nematode infections in
children. Trap Ceogr Med 1993; 45: 11-4-116.
8. Dollery C, ed. Therapeutic Drugs. 1st ed. Edinburgh: Churchilllivingstone, 1991: A31,
M12.
9. Albonico M, Smith PG, Hall A, Chwaya HM, Alawi KS, Savioli L. A randomized
controlled trial comparing mebendazole and albendazole against Ascaris, Trichuris and
hookworm infections. Trans R 50c Trap Med Hyg 199-1; 8S: 385-589.
10. Holzer BR, Frey FJ. Differential efficacy of mebendazole and albendazole against
Necator americanus but not for Trichuris trichiura infestations. Eur I Clin Pharmacal 1987;
32, 635·637.
11. Ramalingam S, Sinniah B, Krishnan U. Albendazole, an effective single dose, broad
spectrum anthelmintic drug. Am I Trop Med Hyg 1983; 32: 984·989.
12. Evans AC, Hollmann AW, De Preez l. Mebendazole 500 mg for single·dose treatment
of nematode infestation. 5 Aft Med J 1987; 72: 665-667.
13. Adams EJ, Stephenson lS, latham MC, Kinoti SN. Physical activity and growth of
Kenya school children with hookworm, Trichuris trichiura and Ascaris lumbricoides
infections are improved after treatment with albendazole. J Nutr 199-1; 124: 1199-12.06.
1-4. Stephenson lS, Latham MC, Adams El. Kinoti SN, Pertet A. Weight gain of Kenyan
school children infected with hookworm, Trichuris trichiura and Ascaris lumbricoides is
improved following once- or twice-yearly treatment with albendazole. I Nutr 1992;
123, 656·665.
15. Stephenson lS, Latham MC, Adams EJ, Kinoti SN, Pertet A. Physical fitness, growth
and appetite of Kenyan school boys with hookworm, Trichuris trichiura and Ascaris
lumbricoides infections are improved four months after a single dose of albendazole. I
Nutr 1993; 123, 1036·10.6.
16. Simeon DT, Grantham-McGreggor SM, Callender JE, Wong MS. Treatment of Trichuris
trichiura infections improves growth, spelling scores and school attendance in some
children. J Nutr 1995; 125: 1 75-1 3.
Accepted 14]an 1998.
EXPRESSION OF SCHIZOPHRENIA
IN BLACK XHOSA-SPEAKING AND
WHITE ENGLISH-SPEAKING
SOUTH AFRICANS
K Ensink, B A Robertson, 0 Ben-Arie, P Hodson, C Tredoux
Objective. To inv:estigate whether schizophrenia manifests
itself differently in Xhosa-speaking South Africans,
compared with English-speaking white South Africans.
Design. A comparative study ·of the presentation of
schizophrenia in two groups of patients.
Settings and subjects. A sample of 63 patients (43 Xhosa-
speaking and 20 English-speaking) admitted to a large
psychiatric hospital for the first time with a diagnosis of
schizophrenia.
Outcome measures. The Present State Examination (PSE) was
used to confirm the clinical diagnosis of schizophrenia.
The Relatives' Rating of Symptoms and Social Behaviour
(KAS-R) was used to obtain information on the behavioural
and emotional expression of schizophrenia.
Results. A significantly higher prevalence of aggressive and
disruptive behaviour was reported by relatives of Xhosa-
speaking patients with schizophrenia of recent onset
compared with English-speaking patients. The PSE elicited
significantly more delusions of persecution, sexual and
fantastic delusions, self-neglect and irritability in the Xhosa-
speaking patients.
Canclusion. Significant differences in the presentation of
schizophrenia, but not its core symptoms, were identified in
. Xhosa-speaking blacks and English-speaking whites.
5 AIr M£d J199 ; 88, 883-887.
Significant differences in the presentation, course and outcome
of schizophrenia have been documented in many societies,I.>
but have received surprisingly little attention in South Africa.
Given the misuse of social and cultural differences for political
purposes, many South African researchers have been critical of
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